EUVIMEDEUVIMED entdecken
Crossref

Validation of non‐invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII

Byeong Geun Song iD, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak iD, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik, Dong Hyun Sinn iD

Liver International · 2023

DOI: 10.1111/liv.15632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Byeong Geun Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Esophageal and Gastric Varices, Hypertension, Portal, Elasticity Imaging Techniques. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Baveno VII consensus introduced the non‐invasive criteria of clinically significant portal hypertension (CSPH) using liver stiffness measurement (LSM). We evaluated the usefulness of the Baveno VII criteria to predict the risk of decompensation in patients with compensated advanced chronic liver disease (cACLD).

Methods

We conducted a retrospective cohort study of 1966 patients with cACLD. Patients were categorized into four groups (CSPH excluded ( n = 619), grey zone (low risk of CSPH ( n = 699), high risk of CSPH ( n = 207)), and CSPH included ( n = 441)) according to Baveno VII consensus. The risk of events was estimated using a Fine and Gray competing risk regression analysis, with liver transplantation and death as competing events. We calculated standardized hazard ratios (sHR) to assess the relative risk of decompensation.

Results

Among 1966 patients, 178 developed decompensations over a median follow‐up of 3.06 (IQR: 1.03–6.00) years. Patients with CSPH had the highest decompensation risk, followed by the grey zone high‐risk group, grey zone low‐risk group, and those without CSPH with 3‐year cumulative risks of 22%, 12%, 3.3%, and 1.4% respectively ( p < .001). Compared to CSPH excluded group, CSPH included group (sHR: 8.00, 95% CI: 4.00–16.0), grey zone high‐risk group (sHR: 6.57, 95% CI: 3.16–13.6), grey zone low‐risk group (sHR: 2.15, 95% CI: 1.04–4.41) had significantly higher risk of decompensation (Gray's test p < .01).

Conclusion

Non‐invasive diagnosis of CSPH according to the Baveno VII criteria can stratify the risk of decompensation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal and Gastric VaricesHypertension, PortalElasticity Imaging TechniquesHumansRetrospective StudiesRisk FactorsLiver CirrhosisPiperidines

Stichwörter der Autor:innen

clinically significant portal hypertensiondecompensationliver stiffness measurementportal hypertensiontransient elastography

Substanzen

4-(3-chlorophenylsulfanyl)piperidinePiperidines

Autor:innen und Institutionen

  • Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

ORCID-Profile: Byeong Geun Song, Geum-Youn Gwak, Dong Hyun Sinn

Zitieren

APA

Song, B. G., Goh, M. J., Kang, W., Gwak, G. Y., Paik, Y. H., Choi, M. S., Lee, J. H., Paik, S. W., & Sinn, D. H. (2023). Validation of non‐invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII. Liver International. https://doi.org/10.1111/liv.15632

Vancouver

Song BG, Goh MJ, Kang W, Gwak GY, Paik YH, Choi MS, et al. Validation of non‐invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII. Liver International. 2023. doi:10.1111/liv.15632

BibTeX
@article{Song2023,
  author = {Song, Byeong Geun and Goh, Myung Ji and Kang, Wonseok and Gwak, Geum-Youn and Paik, Yong-Han and Choi, Moon Seok and Lee, Joon Hyeok and Paik, Seung Woon and Sinn, Dong Hyun},
  title = {Validation of non‐invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII},
  journal = {Liver International},
  year = {2023},
  doi = {10.1111/liv.15632}
}
Kostenlos starten →